Our findings demonstrate that chloroquine treatment reverses endothelial dysfunction by preventing GCH1 degradation via suppression of CHIP-mediated ubiquitination, leading to improved NO synthesis despite unchanged eNOS protein levels. Here, NOS3 is linked to endothelial dysfunction.